Analyse MiRXES USA de la part de marché pour juillet 2026

Alzheimer’s disease (AD) is a leading cause of dementia, characterized by cognitive decline and the accumulation of amyloid-β plaques and neurofibrillary tangles. A recent study from Tulane University used Stereo-seq technology to create a high-resolution spatial transcriptome atlas of the prefrontal cortex (PFC) in AD patients, revealing structural and transcriptional disruptions. Key findings include the downregulation of neuroprotective pathways, increased immune response, and disrupted cell-cell communication, with the transcription factor ZNF460 identified as a potential therapeutic target. These insights enhance our understanding of AD pathology and highlight the importance of Stereo-seq technology in advancing research and potential treatments.